Insights
Latest IR news and announcements for Health Catalyst, Inc. (HCAT).
Health Catalyst, Inc. announces the appointment of Tami Reller to its board of directors, effective October 1, 2026. Reller will serve as audit chair and brings extensive experience in healthcare and technology leadership.
Health Catalyst, Inc. announced the granting of 2,747,385 restricted stock units to new CEO Simeon Kohl as part of his employment inducement. The awards comply with Nasdaq rules and will vest over the next year and beyond.
Health Catalyst has appointed Simeon Kohl as its new CEO and President, effective September 14, 2026. Ben Albert transitions to Chief Business Officer after leading the company through significant strategic initiatives.
Health Catalyst has finalized the sale of Vitalware to Med-Metrix, allowing it to eliminate debt and concentrate on its core technology aimed at improving health system performance and driving measurable improvements in healthcare.
Health Catalyst, Inc. reported its second quarter 2026 results, showing a revenue decline of 13% year-over-year but exceeding revenue guidance. The company successfully divested Vitalware and repaid credit facility debt, enhancing its financial flexibility.
Health Catalyst, Inc. will announce its second quarter 2026 operating results on August 6, 2026, followed by a conference call to discuss the outcomes. The call can be accessed via phone or live webcast.